REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
29/09/2025
Voltar para busca
Dado oficial do USPTO
BAM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BAM
ST13
US500000088428843Classe
35, 41, 42, 44
Pedido
88428843
Registro
6161365
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
23
Atualização mais recente
30/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 41, 42, 44
Data de depósito
14/05/2019
Data de registro
29/09/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/09/2020
Última transação
30/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
07/01/2019
Primeiro uso no comércio
07/01/2019
Código do desenho
4
Tipo de titular
16
Localização do titular
Morrisville, NC
Examinador
ALAO,OREOLUWA
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Syneos Health, LLC
Representantes
Michael A. Geller DLA PIPER LLP (US)
Classificação técnica
Classes Nice
Classe 35Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Strategic business consultinginformation and data collectioncompiling and analyzing data and information for business purposesbusiness data analyticsanalyzing business data to understand and evaluate business performanceall of the aforementioned in the pharmaceuticalbiotechnology and life sciences fields; market analysis and research services; personnel recruitment and placement; recruitment advertising servicesadvertising clinical trials for the purpose of recruiting patientsplacing patients for participation in clinical trials for testing of pharmaceuticals and devices; consulting in sales techniques and sales programs; sales volume tracking for othersall in the pharmaceuticalbiotechnology and life sciences fields; business consulting in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalpharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; regulatory submission managementassisting pharmaceutical and biotechnology companies with preparing and filing applications for new drugs with governmental regulatory bodies; promoting the exchange of health information within the pharmaceuticalbiotechnology and life sciences communities to promote patient adherence within the field of pharmaceuticalbiotechnology and life sciences clinical trials; extended clinical research services for otherscomputerized data management of clinical trials
Classe 41
Education servicesproviding non-downloadable webinarsproviding live workshopsproviding seminars through on-line non-downloadable videosproviding on-line non-downloadable electronic publications in the nature of articles and white papersproviding non-downloadable podcastsall the foregoing in the field of pharmaceutical sales; training services in the field of pharmaceutical sales; providing on-line non-downloadable electronic newsletters and bulletins in the pharmaceuticalbiotechnology and life sciences fields; educational servicesproviding courses offered through on-line non-downloadable videosnon-downloadable webinarslive workshopsproviding online non-downloadable electronic publications in the nature of articles and white papersproviding non-downloadable podcastsall the foregoing in the field of clinical trials
Classe 42
Medical and scientific data analysis research services for othersconducting and analyzing clinical trials in the pharmaceuticalbiotechnology and life sciences fields; pharmaceutical drug development servicesdeveloping clinical trial methodologies; consulting services in the area of pharmaceutical product clinical testing; extended clinical research services for others for medical purposesbiostatistical analysis for scientific research purposespreclinical research in the field of pharmaceuticalsbiotechnologymedical sciencesdevelopment evaluationclinical feasibility assessment of protocols and patient recruitment strategiesrepairing flawed clinical trials and dossiersmedical and scientific research in the nature of conducting clinical trials for othersstrategic clinical research portfolio managementconsulting services for others in the project management of clinical research; extended clinical research services for others in the field of pharmaceuticalsbiotechnologylife sciencesbiostatistical analysis for scientific research purposes; providing life science and scientific research information to physicians and other health care professionalspatientsmedicalpharmaceutical and biotechnology companies; providing regulatory compliant technical writing services in the field of medical research and clinical studies; consulting services in the field of contract clinical research and contract product development
Classe 44
Providing medical information to physiciansother health care professionals and medical patients; providing health information regarding the medications and health care products of others through e-mail alerts and push notificationsproviding information concerning product discontinuations; providing health information concerning new formulations of medications and health care products of others through e-mail alerts and push notificationsproviding information in the field of pharmaceutical products development; providing health information concerning bottle changes of medications and health care products of others through e-mail alerts and push notificationsproviding information in the field of bottle product designseasonal information in the nature of reports on pharmaceutical products development
Publicações
Histórico de despachos e eventos da marca no USPTO.
23 publicações encontradas
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/10/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
15/03/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
29/09/2020
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
23/08/2020
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
14/05/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/04/2020
PUBO
PUBLISHED FOR OPPOSITION
14/04/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/03/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
03/03/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/03/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
03/03/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/02/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/02/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/02/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/08/2019
GNRT
NON-FINAL ACTION E-MAILED
07/08/2019
CNRT
NON-FINAL ACTION WRITTEN
07/08/2019
DOCK
ASSIGNED TO EXAMINER
31/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/05/2019
NWAP
NEW APPLICATION ENTERED
17/05/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BAM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.